Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Authors

    Page :A6

    
• • ·Information for Readers

    Page :A8

    

• Editorials

  • ·Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities

    Page :1-3

    Gregory Y.H. Lip

    
  • ·Evaluating diagnostic tests—should the same methods apply?

    Page :4-6

    Jenny A. Doust, Jonathon C. Craig

     

• AHJ at the Meetings

  • ·Late-breaking trials summary from the 2008 American College of Cardiology Scientific Sessions, March 29 to April 1, Chicago, IL

    Page :7-12

    Renato D. Lopes, Mark Chan, Chiara Melloni, E. Marc Jolicoeur, Larry A. Allen, Bimal R. Shah, Jason N. Katz, Jeffrey S. Berger, Jonathan P. Piccini

    

• Curriculum in Cardiology

  • ·Body mass index and mortality in heart failure: A meta-analysis

    Page :13-22

    Antigone Oreopoulos, Raj Padwal, Kamyar Kalantar-Zadeh, Gregg C. Fonarow, Colleen M. Norris, Finlay A. McAlister

    Résumé Résumé Plan Plan  
  • ·Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone

    Page :23-30

    Adrian V. Hernandez, Esteban Walker, John P.A. Ioannidis, Michael W. Kattan

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapies

    Page :31-36

    Niteesh K. Choudhry, Troyen Brennan, Michele Toscano, Claire Spettell, Robert J. Glynn, Mark Rubino, Sebastian Schneeweiss, Alan M. Brookhart, Joaquim Fernandes, Susan Mathew, Blake Christiansen, Elliott M. Antman, Jerry Avorn, William H. Shrank

    Résumé Résumé Plan Plan
  • ·Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

    Page :37-43

    Jose Antonio Marin-Neto, Anis Rassi, Carlos A. Morillo, Alvaro Avezum, Stuart J. Connolly, Sergio Sosa-Estani, Fernando Rosas, Salim Yusuf, on behalf of BENEFIT Investigators

    Résumé Résumé Plan Plan
  • ·The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale

    Page :44-56

    Roxana Mehran, Bruce Brodie, David A. Cox, Cindy L. Grines, Barry Rutherford, Deepak L. Bhatt, George Dangas, Fred Feit, E. Magnus Ohman, Helen Parise, Martin Fahy, Alexandra J. Lansky, Gregg W. Stone

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme

    Page :57-64

    Stephan Rietbrock, Emma Heeley, Jonathan Plumb, Tjeerd van Staa

    Résumé Résumé Plan Plan  
  • ·Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: A prospective randomized trial

    Page :65-70

    Chia-Ti Tsai, Ling-Ping Lai, Juey-Jen Hwang, Yi-Chih Wang, Fu-Tien Chiang, Jiunn-Lee Lin

    Résumé Résumé Plan Plan  
  • ·N-terminal pro–brain natriuretic peptide testing in the emergency department: Beneficial effects on hospitalization, costs, and outcome

    Page :71-77

    Joost H.W. Rutten, Ewout W. Steyerberg, Frans Boomsma, Jan L.C.M. van Saase, Jaap W. Deckers, Henk C. Hoogsteden, Jan Lindemans, Anton H. van den Meiracker

    Résumé Résumé Plan Plan  
  • ·Impact of do-not-resuscitation orders on quality of care performance measures in patients hospitalized with acute heart failure

    Page :78-84

    Joline L.T. Chen, Jonathan Sosnov, Darleen Lessard, Robert J. Goldberg

    Résumé Résumé Plan Plan
  • ·Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

    Page :85-91

    Vanessa Roldán, Francisco Marín, Juan R. Gimeno, Francisco Ruiz-Espejo, Josefa González, Eloisa Feliu, Antonio García-Honrubia, Daniel Saura, Gonzalo de la Morena, Mariano Valdés, Vicente Vicente

    Résumé Résumé Plan Plan  
  • ·Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy

    Page :92

    Martin Landsberger, Alexander Staudt, Sangita Choudhury, Christiane Trimpert, Lars R. Herda, Karin Klingel, Reinhard Kandolf, Heinz-Peter Schultheiss, Heyo K. Kroemer, Uwe Völker, Stephan B. Felix

    Résumé Résumé Plan Plan  
  • ·Exercise capacity and biventricular function in adult patients with repaired tetralogy of Fallot

    Page :100-105

    Ahmed Samman, Markus Schwerzmann, Olga H. Balint, David Tanous, Andrew Redington, John Granton, Samuel C. Siu, Candice K. Silversides

    Résumé Résumé Plan Plan  
  • ·An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration

    Page :106-111

    Matt Fisher, Mary Cushman, Volker Knappertz, George Howard

    Résumé Résumé Plan Plan  
  • ·Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004

    Page :112-119

    Heli Ghandehari, Sachin Kamal-Bahl, Nathan D. Wong

    Résumé Résumé Plan Plan  
  • ·Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention

    Page :120-124

    Christopher B. Overgaard, Joan Ivanov, Peter H. Seidelin, Mina Todorov, Karen Mackie, Vladimír Džavík

    Résumé Résumé Plan Plan  
  • ·Safety and effectiveness of drug-eluting stents among diabetic patients: A propensity analysis

    Page :125-134

    Dennis T. Ko, Maria Chiu, Peter C. Austin, James Bowen, Eric A. Cohen, Jack V. Tu

    Résumé Résumé Plan Plan  
  • ·One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study

    Page :135-140

    Olivier F. Bertrand, Josep Rodés-Cabau, Éric Larose, Can Manh Nguyen, Louis Roy, Jean-Pierre Déry, Javier Courtis, Isabelle Nault, Paul Poirier, Olivier Costerousse, Robert De Larochellière

    Résumé Résumé Plan Plan  
  • ·Correlates of late and very late thrombosis of drug eluting stents

    Page :141-147

    Gregory J. Mishkel, Anna L. Moore, Steve Markwell, Marc E. Shelton

    Résumé Résumé Plan Plan  
  • ·Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial

    Page :148-154

    Lyne Lalonde, Josée Martineau, Normand Blais, Martine Montigny, Jeffrey Ginsberg, Martine Fournier, Djamal Berbiche, Marie-Claude Vanier, Lucie Blais, Sylvie Perreault, Isabel Rodrigues

    Résumé Résumé Plan Plan  
  • ·Do specialty cardiac hospitals have greater adherence to acute myocardial infarction and heart failure process measures? An empirical assessment using Medicare quality measures : Quality of care in cardiac specialty hospitals

    Page :155-160

    Ioana Popescu, Brahmajee K. Nallamothu, Mary S. Vaughan-Sarrazin, Peter Cram

    Résumé Résumé Plan Plan  
  • ·Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy

    Page :161-169

    Sharie B. Parks, Jessica D. Kushner, Deirdre Nauman, Donna Burgess, Susan Ludwigsen, Amanda Peterson, Duanxiang Li, Petra Jakobs, Michael Litt, Charles B. Porter, Peter S. Rahko, Ray E. Hershberger

    Résumé Résumé Plan Plan  
  • ·Factors that influence the use of ambulance in acute coronary syndrome

    Page :170-176

    Marie Thuresson, Marianne Berglin Jarlöv, Bertil Lindahl, Leif Svensson, Crister Zedigh, Johan Herlitz

    Résumé Résumé Plan Plan
  • ·Smoking status and antithrombin therapy in patients with non–ST-segment elevation acute coronary syndrome

    Page :177-184

    Steve Leung, Dianne Gallup, Kenneth W. Mahaffey, Marc Cohen, Elliott M. Antman, Shaun G. Goodman, Robert A. Harrington, Anatoly Langer, Philip Aylward, James J. Ferguson, Robert M. Califf, on behalf of the SYNERGY Trial Investigators

    Résumé Résumé Plan Plan
  • ·Patterns of transfer for patients with non–ST-segment elevation acute coronary syndrome from community to tertiary care hospitals

    Page :185-192

    Matthew T. Roe, Anita Y. Chen, Elizabeth R. Delong, William E. Boden, James E. Calvin, Charles B. Cairns, Sidney C. Smith, Charles V. Pollack, Ralph G. Brindis, Robert M. Califf, W. Brian Gibler, E. Magnus Ohman, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome

    Page :193-200

    Boris Bigalke, Tobias Geisler, Konstantinos Stellos, Harald Langer, Karin Daub, Elisabeth Kremmer, Peter Seizer, Andreas E. May, Stephan Lindemann, Meinrad Gawaz

    Résumé Résumé Plan Plan  

• Letters to the Editors

  • ·Should an angiotensin-converting enzyme inhibitor be given at the time of reperfusion therapy in acute myocardial infarction?

    Page :e1

    Craig Steven McLachlan, Ryan Ocsan, Brett Hambly, Reida El Oakley

    
  • ·Recovery of normal ventricular function in patients with dilated cardiomyopathy: Relevance of the etiology

    Page :e3

    Pasquale Santangeli, Francesca Marzo, Andrea Macchione, Fulvio Bellocci, Filippo Crea, Maurizio Pieroni

    
  • ·Obesity and postoperative atrial fibrillation. Is there no connection? : Comment on: Wanahita et al. “Atrial fibrillation and obesity—results of a meta-analysis”

    Page :e5

    Maciej Banach, Jan Henryk Goch, Murat Ugurlucan, Jacek Rysz, Dimitri P. Mikhailidis